China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.

A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that ...

Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.

Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...